• Thurs news: GSK inks 2nd neuro pact in weeks. Teva episodic migraine trial. FDA clears AZ’s Imfinzi for aggressive lung cancer. Novartis fails to block generic Entresto. Nuvig gets immune drug funding. See more on our front page

Dendreon

Anonymous board for Dendreon
Replies
0
Views
365
anonymous
Replies
16
Views
8K
anonymous
Replies
14
Views
4K
anonymous
Replies
5
Views
4K
anonymous
Replies
0
Views
1K
anonymous
Replies
13
Views
6K
anonymous
Replies
0
Views
2K
anonymous
Replies
2
Views
2K
anonymous
Replies
1
Views
2K
anonymous
Replies
2
Views
2K
anonymous
Replies
18
Views
11K
anonymous
Replies
6
Views
5K
anonymous
Replies
2
Views
3K
anonymous
Replies
3
Views
4K
anonymous
Replies
2
Views
3K
anonymous
Replies
2
Views
3K
anonymous